INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹-7.99 | ₹10.68 | ₹15.44 | ₹16.80 | ₹10.10 |
What is the latest Earnings Per Share (EPS) of INDOCO REMEDIES ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹-7.99 |
| Mar2024 | ₹10.68 |
| Mar2023 | ₹15.44 |
| Mar2022 | ₹16.80 |
| Mar2021 | ₹10.10 |
How is Earnings Per Share (EPS) of INDOCO REMEDIES Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹-7.99 | Negative | |
| Mar2024 | ₹10.68 | -30.83 | |
| Mar2023 | ₹15.44 | -8.10 | |
| Mar2022 | ₹16.80 | 66.34 | |
| Mar2021 | ₹10.10 | - | |
Compare Earnings Per Share (EPS) of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,553.0 Cr | -3.6% | -8.5% | -12.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,471.0 Cr | 0.3% | 4.1% | -9.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,294.0 Cr | -1.7% | 8.5% | 13.2% | Stock Analytics | |
| CIPLA | ₹127,946.0 Cr | -3.4% | 3% | 4.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,691.0 Cr | 0.7% | -0.5% | 7.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,214.0 Cr | 0.2% | -1.1% | -3.6% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -3.6% |
-8.5% |
-12.7% |
| SENSEX | 1% |
3.3% |
4.5% |
You may also like the below Video Courses